• Follow
  • Follow
  • Menu Item

Log in

Start free trial
  • Reports
    • Diagnostic Testing & Emerging Technologies
    • Lab Compliance Advisor
    • Laboratory Industry Report
    • National Lab Reporter
  • Articles
    • Diagnostic Testing and Emerging Technologies
      • DTC-dtet
      • Earnings-dtet
      • Emerging Tests-dtet
      • FDA-dtet
      • G2 Insider-dtet
    • Lab Compliance Advisor
      • Accreditation-lca
      • Brief Your CEO-lca
      • CLIA-lca
      • CMS-lca
      • Coding-lca
      • Compliance Corner-lca
      • Compliance Guidance-lca
      • Compliance Officers-lca
      • Compliance Perspectives-lca
      • Compliance Plans-lca
      • Compliance-lca
      • DOJ-lca
      • Employment-lca
      • Enforcement-lca
      • False Claims-lca
      • FDA-lca
    • Laboratory Industry Report
      • Capital-lir
      • CMS-lir
      • Deals-lir
      • Dx Pipeline-lir
      • Earnings-lir
      • Enforcement-lir
      • FDA-lir
      • Fee Schedules-lir
      • Funding-lir
    • National Lab Reporter
      • Guidelines at a Glance-nir
      • Health care reform-nir
      • HIPAA-nir
      • Labs in Court-nir
      • Legislation-nir
      • News-nir
      • OIG-nir
      • Reimbursement-nir
      • Safety-nir
  • News
  • Industry Perspectives
  • Webinars
  • Store

Diagnostic Testing and Emerging Technologies

LAB COMPLIANCE ADVISOR

LABORATORY INDUSTRY REPORT

NATIONAL LAB REPORTER

Expert Q&A: Recent Trends in the Clinical Lab

Expert Q&A: Recent Trends in the Clinical Lab

by Rachel Muenz | Mar 23, 2023 | Diagnostic Testing and Emerging Technologies, Testing Trends-dtet

G2 Intelligence managing editor Rachel Muenz chats with lab leader Stephanie Whitehead about recent developments affecting clinical labs.

This content is for Paid Members only.
Login Register
AI Combined with DM and ABUS Can Improve Breast Cancer Detection

AI Combined with DM and ABUS Can Improve Breast Cancer Detection

by Glenn S. Demby | Feb 22, 2023 | Diagnostic Testing and Emerging Technologies, Special Focus-dtet

Researchers found that combining AI with both imaging technologies can improve the detection of cancer in women with dense breasts.

This content is for Paid Members only.
Login Register
Researchers Report First “Routine Clinical Use” of AI for Breast Biopsies

Researchers Report First “Routine Clinical Use” of AI for Breast Biopsies

by Rachel Muenz | Feb 1, 2023 | News

While AI as a diagnostic tool is still years away from regular clinical use, recent research is an important step.

An AI Invasion: Improving Breast Cancer Biopsies

An AI Invasion: Improving Breast Cancer Biopsies

by Miriam Bergeret, MSc | Jan 27, 2023 | Diagnostic Testing and Emerging Technologies, Special Focus-dtet

Researchers report the first-ever routine clinical use of an AI-based tool for breast cancer biopsies in a pathology lab.

This content is for Paid Members only.
Login Register
White House Proposes New AI “Bill of Rights”

White House Proposes New AI “Bill of Rights”

by Glenn S. Demby | Nov 23, 2022 | News

US takes first steps to rein in abusive and privacy-invasive use of AI by corporations.

« Older Entries

Log In


Join Now | Lost Password?

  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
Copyright © 2023 G2Intelligence.com